81 related articles for article (PubMed ID: 9764841)
1. Differential regulation of epidermal cell tumor-antigen presentation by IL-1alpha and IL-1beta.
Beissert S; Hosoi J; Stratigos A; Brissette J; Grabbe S; Schwarz T; Granstein RD
J Invest Dermatol; 1998 Oct; 111(4):609-15. PubMed ID: 9764841
[TBL] [Abstract][Full Text] [Related]
2. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Beissert S; Hosoi J; Grabbe S; Asahina A; Granstein RD
J Immunol; 1995 Feb; 154(3):1280-6. PubMed ID: 7822797
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Grabbe S; Bruvers S; Granstein RD
J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
[TBL] [Abstract][Full Text] [Related]
4. Tumor antigen presentation by murine epidermal cells.
Grabbe S; Bruvers S; Gallo RL; Knisely TL; Nazareno R; Granstein RD
J Immunol; 1991 May; 146(10):3656-61. PubMed ID: 2026885
[TBL] [Abstract][Full Text] [Related]
5. Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: modulation by granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and ultraviolet radiation.
Grabbe S; Bruvers S; Lindgren AM; Hosoi J; Tan KC; Granstein RD
J Leukoc Biol; 1992 Aug; 52(2):209-17. PubMed ID: 1506778
[TBL] [Abstract][Full Text] [Related]
6. Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content.
Beissert S; Ullrich SE; Hosoi J; Granstein RD
J Leukoc Biol; 1995 Aug; 58(2):234-40. PubMed ID: 7643016
[TBL] [Abstract][Full Text] [Related]
7. Tumor antigen presentation by dermal antigen-presenting cells.
Campton K; Ding W; Yan Z; Ozawa H; Seiffert K; Miranda E; Lonati A; Beissert S; Granstein RD
J Invest Dermatol; 2000 Jul; 115(1):57-61. PubMed ID: 10886508
[TBL] [Abstract][Full Text] [Related]
8. Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA.
Granstein RD; Ding W; Ozawa H
J Invest Dermatol; 2000 Apr; 114(4):632-6. PubMed ID: 10733665
[TBL] [Abstract][Full Text] [Related]
9. Epidermal cell presentation of tumor-associated antigens for induction of tolerance.
Tan KC; Hosoi J; Grabbe S; Asahina A; Granstein RD
J Immunol; 1994 Jul; 153(2):760-7. PubMed ID: 7912706
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tumor antigen presentation by urocanic acid.
Beissert S; Mohammad T; Torri H; Lonati A; Yan Z; Morrison H; Granstein RD
J Immunol; 1997 Jul; 159(1):92-6. PubMed ID: 9200443
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide.
Asahina A; Hosoi J; Beissert S; Stratigos A; Granstein RD
J Immunol; 1995 Apr; 154(7):3056-61. PubMed ID: 7897198
[TBL] [Abstract][Full Text] [Related]
12. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses.
Nambu A; Nakae S; Iwakura Y
Int Immunol; 2006 May; 18(5):701-12. PubMed ID: 16569679
[TBL] [Abstract][Full Text] [Related]
13. Effects of immunomodulatory cytokines on the presentation of tumor-associated antigens by epidermal Langerhans cells.
Grabbe S; Bruvers S; Granstein RD
J Invest Dermatol; 1992 Nov; 99(5):66S-68S. PubMed ID: 1431232
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor gene transfer to dendritic cells or epidermal cells augments their antigen-presenting function including induction of anti-tumor immunity.
Ozawa H; Ding W; Torii H; Hosoi J; Seiffert K; Campton K; Hackett NR; Topf N; Crystal RG; Granstein RD
J Invest Dermatol; 1999 Dec; 113(6):999-1005. PubMed ID: 10594743
[TBL] [Abstract][Full Text] [Related]
15. Differential antigen presentation in tumor immunity.
Schatten S; Drebin JA; Granstein RD; Greene MI
Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
[TBL] [Abstract][Full Text] [Related]
16. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice.
Wang B; Zhuang L; Fujisawa H; Shinder GA; Feliciani C; Shivji GM; Suzuki H; Amerio P; Toto P; Sauder DN
J Immunol; 1999 Jan; 162(1):277-83. PubMed ID: 9886396
[TBL] [Abstract][Full Text] [Related]
17. Aqueous humor inhibits epidermal cell antigen-presenting function.
Hosoi J; Grabbe S; Knisely TL; Granstein RD
Reg Immunol; 1993; 5(5):279-84. PubMed ID: 8148237
[TBL] [Abstract][Full Text] [Related]
18. Epidermal Langerhans' cell induction of immunity against an ultraviolet-induced skin tumour.
Cavanagh LL; Sluyter R; Henderson KG; Barnetson RS; Halliday GM
Immunology; 1996 Mar; 87(3):475-80. PubMed ID: 8778036
[TBL] [Abstract][Full Text] [Related]
19. Migration of langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF-alpha and IL-1beta.
Stoitzner P; Zanella M; Ortner U; Lukas M; Tagwerker A; Janke K; Lutz MB; Schuler G; Echtenacher B; Ryffel B; Koch F; Romani N
J Leukoc Biol; 1999 Sep; 66(3):462-70. PubMed ID: 10496317
[TBL] [Abstract][Full Text] [Related]
20. Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in mice.
Cunha TM; Verri WA; Valério DA; Guerrero AT; Nogueira LG; Vieira SM; Souza DG; Teixeira MM; Poole S; Ferreira SH; Cunha FQ
Eur J Pain; 2008 Nov; 12(8):1059-68. PubMed ID: 18372199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
